Skip to content

Application of Concentrated Growth Factors in Alveolar Ridge Preservation

Study on the Effect of Concentrated Growth Factor in Promoting the Regeneration and Preservation of Soft and Hard Tissues

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06308536
Enrollment
20
Registered
2024-03-13
Start date
2023-05-09
Completion date
2025-04-01
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Ridge Preservation, Concentrated Growth Factor

Keywords

extraction site preservation, concentrated growth factor, CGF, soft and hard tissue regeneration

Brief summary

To explore the role of CGF in the regeneration or preservation of soft and hard tissues during tooth extraction site preservation surgery.

Detailed description

A prospective, randomized controlled trial is designed to explore the role of CGF in the regeneration or preservation of soft and hard tissues in extraction site preservation. Using random number table, 20 patients were randomly divided into 4 groups using different filling materials in the extraction socket and materials for the wound sealing. Group A (5cases): bone powder + collagen membrane; Group B (5 cases): bone powder + collagen membrane + CGF membrane; Group C (5 cases): bone powder mixed CGF gel + collagen membrane + CGF membrane; Group D (5 cases): bone powder + CGF membrane. Extraction and site preservation surgery were performed by the same physician and clinical follow-up was more than 6 months after surgery. The four groups will be compared on several variables, including the changes in pain score, Landry wound healing index, membrane exposure area, keratinized gingival width, buccolingual gingival width, alveolar crest width and height.

Interventions

PROCEDUREbone powder + collagen membrane

Fill the extraction socket with Bio-Oss® bone powder, and cover the extraction wound with Bio-Gide® collagen membrane.

PROCEDUREbone powder + collagen membrane + CGF membrane

Fill the extraction socket with Bio-Oss® bone powder, and cover the extraction wound with Bio-Gide® collagen membrane plus CGF membrane(CGF gel is pressed into a film)

PROCEDUREbone powder mixed wih CGF gel + collagen membrane + CGF membrane

Fill the extraction socket with Bio-Oss® bone powder mixed with CGF gel (CGF gel is cutted into granules ), and cover the extraction wound with Bio-Gide® collagen membrane plus CGF membrane(CGF gel is pressed into a film)

PROCEDUREbone powder + CGF membrane

Fill the extraction socket with Bio-Oss® bone powder and cover the extraction wound with CGF membrane(CGF gel is pressed into a film)

Sponsors

The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Voluntarily participate in this trial and sign a written informed consent; Patients aged 25 ≤ age ≤ 45 years; The combination of intraoral and imaging examinations confirms that the affected tooth has no preservation value, requires tooth extraction, and the patient is willing to use site preservation; No progressive periodontal disease or acute apical periodontitis in the affected teeth; No long-term history of oral bisphosphonates; Non smoking patients; No systemic diseases such as diabetes and hypertension.

Exclusion criteria

Patients who have difficulty tolerating surgery; Patients under 25 years old or above 45 years old; The whole body is accompanied by hypertension, diabetes and other serious systemic diseases, which need to be controlled by drugs; Patients who take oral medication that affects bone metabolism for at least one month due to the need for disease treatment; Patients who take medication that may affect platelet function was used within 3 months due to the need for disease treatment; Patients unable to undergo X-ray imaging examination due to pregnancy or preparation after site preservation surgery; Patients who Smoke; The apical and periodontal inflammation is in the acute phase (purulent phase) Regular follow-up or follow-up for more than 6 months is not allowed

Design outcomes

Primary

MeasureTime frameDescription
the width of keratinized gingivapreoperative, 3 months and 6 months after surgerythe width of keratinized gingiva measured by periodontal probe
the horizontal width (from buccal to lingual at the alveolar top ) of gingivaimmediate , 3 months and 6 months postoperativethe horizontal width of gingiva measured by periodontal probe
the horizontal bone resorption of alveolar crestimmediate , 3 months and 6 months postoperativeCompared with immediate postoperative, the horizontal width of alveolar crest decreased at 3months and 6 months, postoperative alveolar bone resorption progressed with time
the vertical bone resorption of alveolar crestimmediate , 3 months and 6 months postoperativethe vertical width of alveolar crest decreased at 3months and 6 months postoperative compared with the immediate postoperative
the average gray value of alveolar boneimmediate , 3 months and 6 months postoperativethe average gray value of alveolar bone

Secondary

MeasureTime frameDescription
Landry wound healing index7 days and 12 days after surgeryscores:1,2,3,4,5 according to the gingival healing status
reduction in membrane exposure area7 days,12 days and one month after surgerymembrane exposure area reduce different in four groups
pain score1day, 3days after surgerysscores: 2,4,6,8,10 using the Wong-Baker facial pain scale revision (FPS-R)

Countries

China

Contacts

Primary ContactGenying Zhuang, Master
20918620@zju.edu.cn13758195143

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026